(Q28201920)

29 December 2023

author

Panayiotis Loukopoulos

1

object named as

Loukopoulos P

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12724563

29 December 2023

author name string

J R Thornton

2

0 references

W F Robinson

3

0 references

Thornton JR

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12724563

29 December 2023

Robinson WF

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12724563

full work available at URL

29 December 2023

language of work or name

English

0 references

publication date

May 2003

0 references

https://journals.sagepub.com/doi/pdf/10.1354/vp.40-3-237

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12724563

http://journals.sagepub.com/doi/pdf/10.1354/vp.40-3-237

29 December 2023

1 reference

http://journals.sagepub.com/doi/full-xml/10.1354/vp.40-3-237

29 December 2023

1 reference

Cancer progression and p53.

29 December 2023

0 references

40

0 references

issue

3

0 references

page(s)

237-48

0 references

cites work

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Accumulation of nuclear p53 and tumor progression in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Co-localization of endogenous and exogenous p53 proteins in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Predictive value of Ki-67, p53 protein, and DNA content in the diagnosis of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

T antigen is bound to a host protein in SY40-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Sun-exposure- and aging-dependent p53 protein accumulation results in growth advantage for tumour cells in carcinogenesis of nonmelanocytic skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Primary and secondary bone tumours in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Deacetylation of p53 modulates its effect on cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Prognostic Significance of Ki-67 and p53 Immunoreactivity in Cutaneous Squamous Cell Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Some Prognostic and Epidemiologic Factors in Canine Osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

The challenge of p53 as prognostic and predictive factor in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Percent tumor necrosis as a predictor of treatment response in canine osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Prognostic significance of p53 gene mutations and p53 protein expression in synovial sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Multifactorial analysis of p53 alteration in human cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Management of canine appendicular osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Detection of canine oral papillomavirus-DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Isolation of canine p53 cDNA and detailed characterization of the full length canine p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Identification of tumour-associated and germ line p53 mutations in canine mammary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

Increased expression of mutant forms of p53 oncogene in primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

21 January 2018

No room at the p53 inn

1 reference

https://api.crossref.org/works/10.1354%2FVP.40-3-237

p53 protein in endometrial cancer is related to proliferative activity and prognosis but not to expression of p21 protein

21 January 2018

1

1 reference

Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993)

29 December 2023

3

1 reference

Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck

29 December 2023

5

1 reference

p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression?

29 December 2023

10

1 reference

Oncogenes, p53, and tumor angiogenesis

29 December 2023

12

1 reference

Genomic organization of the canine p53 gene and its mutational status in canine mammary neoplasia

29 December 2023

13

1 reference

Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas

29 December 2023

17

1 reference

Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer

29 December 2023

19

1 reference

Combined role of tumor angiogenesis,bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma

29 December 2023

31

1 reference

Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors

29 December 2023

32

1 reference

p21 expression in colorectal carcinomas: a study on 103 cases with analysis of p53 gene mutation/expression and clinic-pathological correlations

29 December 2023

33

1 reference

Chromosomal assignment of seven genes on canine chromosomes by fluorescence in situ hybridization

29 December 2023

35

1 reference

Prognostic factors in dogs with osteosarcomas of the flat or irregular bones

29 December 2023

37

1 reference

Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus

29 December 2023

44

1 reference

Immunohistochemical detection of p53 and c-myc proteins in canine mammary tumours

29 December 2023

45

1 reference

Immunohistochemical detection of p53 and p21 proteins in canine testicular tumours

29 December 2023

46

1 reference

Glycoprotein CD44 expression in colorectal neoplasms. An immuno-histochemical study including correlation with cathepsin D, extracellular matrix components, p53, Rb, bcl-2, c-erbB-2, EGFR and proliferation indices

29 December 2023

47

1 reference

Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors

29 December 2023

48

1 reference

Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog

29 December 2023

49

1 reference

p53 protein expression in colorectal adenomas: an immunohistochemical study using an antigen retrieval system

29 December 2023

53

1 reference

Expression of proliferating cell nuclear antigen (PC10), p53 protein and c-erbB-2 in renal adenocarcinoma

29 December 2023

60

1 reference

p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate

29 December 2023

62

1 reference

Clinical implication of screening p53 gene mutations in head and neck squamous cell carcinomas

29 December 2023

64

1 reference

Novel canine tumour suppressor gene p53 mutations in cases of skin and mammary neoplasms

29 December 2023

68

1 reference

Cytogenetic, ras, and p53: studies in cases of canine neoplasms (hemangiopericytoma, mastocytoma, histiocytoma, chloroma)

29 December 2023

69

1 reference

Canine tumour suppressor gene p53--mutation in a case of adenoma of circumanal glands

29 December 2023

70

1 reference

Dysregulation of beta-catenin is common in canine sporadic colorectal tumors

29 December 2023

71

1 reference

p53 gene mutations occurring in spontaneous benign and malignant mammary tumors of the dog

29 December 2023

76

1 reference

Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer

29 December 2023

77

1 reference

Mutational analysis of the tumour suppressor gene p53 in lymphosarcoma in two bull mastiffs

29 December 2023

78

1 reference

Nucleotide sequence of a highly conserved region of the canine p53 tumour suppressor gene

29 December 2023

79

1 reference

Clinicopathologic correlation of p53 protein overexpression in adenoma and carcinoma of the ampulla of Vater

29 December 2023

82

1 reference

Antigen retrieval techniques in immunohistochemistry: comparison of different methods

29 December 2023

85

1 reference

p53 tumor suppressor protein overexpression in osteogenic tumors of dogs

29 December 2023

89

1 reference

Clinical relevance of p53 index and expression of proliferating cell nuclear antigen and Ki-67 in gastric cancer

29 December 2023

92

1 reference

Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis

29 December 2023

94

1 reference

Canine mandibular osteosarcoma: 51 cases (1980-1992)

29 December 2023

99

1 reference

Amputation and cisplatin for treatment of canine osteosarcoma

29 December 2023

101

1 reference

Immunohistochemical detection of P53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats and dogs

29 December 2023

104

1 reference

Journal of the National Cancer Institute

29 December 2023

106

36

1137

Tjalma RA

1966

1 reference

P53 gene mutations in osteosarcomas in the dog

29 December 2023

107

1 reference

Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1-2M0 prostatic adenocarcinoma

29 December 2023

112

1 reference

p53 and P-glycoprotein expression are significant prognostic markers in advanced head and neck cancer treated with chemo/radiotherapy

29 December 2023

114

1 reference

Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer

29 December 2023

116

1 reference

The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue

29 December 2023

118

1 reference

29 December 2023

Identifiers

DOI

10.1354/VP.40-3-237

0 references